Network Pharmacology and Transcriptomics Reveal the Mechanism of GuaLouQuMaiWan in Treatment of Type 2 Diabetes and Its Active Small Molecular Compound

The main pathophysiological abnormalities in type 2 diabetes (T2D) include pancreatic β-cell dysfunction and insulin resistance. Due to hyperglycemia, patients receive long-term treatment. However, side effects and drug tolerance usually lead to treatment failure. GuaLouQuMaiWan (GLQMW), a common tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Jiahao, Zhou, Yuheng, Liao, Li, Yu, Liping, Yuan, Ping, Zhang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560855/
https://www.ncbi.nlm.nih.gov/pubmed/36248223
http://dx.doi.org/10.1155/2022/2736504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560855/
https://www.ncbi.nlm.nih.gov/pubmed/36248223
http://dx.doi.org/10.1155/2022/2736504

Ejemplares similares